Peer-Reviewed Original Research Articles |
| 1. | Wen CP, Lin J, Yang YC, Tsai MK, Tsao CK, Etzel C, Huang M, Hsu CY, Ye Y, Mishra L, Hawk E, Wu X. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. J Natl Cancer Inst 104(20):1599-611, 10/2012. PMID: 23073549. |
| 2. | Lin J, Lu C, Stewart DJ, Gu J, Huang M, Chang DW, Lippman SM, Wu X. Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis 33(9):1699-706, 9/2012. e-Pub 6/2012. PMID: 22665367. |
| 3. | Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res 18(14):3982-91, 7/15/2012. e-Pub 6/1/2012. PMID: 22661538. |
| 4. | Lin M, Eng C, Hawk ET, Huang M, Lin J, Gu J, Ellis LM, Wu X. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma. Cancer. e-Pub 6/6/2012. PMCID: PMC3465518. |
| 5. | Wei H, Ke HL, Lin J, Shete S, Wood CG, Hildebrandt MA. MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk. Mol Carcinog. e-Pub 4/19/2012. PMCID: PMC3424388. |
| 6. | Lin M, Eng C, Hawk ET, Huang M, Greisinger AJ, Gu J, Ellis LM, Wu X, Lin J. Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma. Carcinogenesis 33(4):841-7, 4/2012. e-Pub 2/8/2012. PMCID: PMC3324446. |
| 7. | Hildebrandt MA, Tan W, Tamboli P, Huang M, Ye Y, Lin J, Lee JS, Wood CG, Wu X. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis 33(4):799-803, 4/2012. e-Pub 1/19/2012. PMCID: PMC3324439. |
| 8. | Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Genetic Variations in Epigenetic Genes Are Predictors of Recurrence in Stage I or II Non-Small Cell Lung Cancer Patients. Clin Cancer Res 18(2):585-92, 1/15/2012. PMCID: PMC3373176. |
| 9. | Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG, Prokhortchouk E, Gaborieau V, Jacobs KB, Chow WH, Toro JR, Zaridze D, Lin J, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Jinga V, Bencko V, Slamova A, Holcatova I, Navratilova M, Janout V, Boffetta P, Colt JS, Davis FG, Schwartz KL, Banks RE, Selby PJ, Harnden P, Berg CD, Hsing AW, Grubb RL, Boeing H, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, Duell EJ, Quirós JR, Sanchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Peeters PH, Trichopoulos D, Linseisen J, Ljungberg B, Overvad K, Tjønneland A, Romieu I, Riboli E, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Pharoah PD, Easton DF, Albanes D, Virtamo J, Vatten L, Hveem K, Fletcher T, Koppova K, Cussenot O, Cancel-Tassin G, Benhamou S, Hildebrandt MA, Pu X, Foglio M, Lechner D, Hutchinson A, Yeager M, Fraumeni JF, Lathrop M, Skryabin KG, McKay JD, Gu J, Brennan P, Chanock SJ. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet 21(2):456-62, 1/2012. e-Pub 10/2011. PMCID: PMC3250258. |
| 10. | Lin J, Forman MR, Wang J, Grossman HB, Chen M, Dinney CP, Hawk ET, Wu X. Intake of red meat and heterocyclic amines, metabolic pathway genes, and bladder cancer risk. Int J Cancer. e-Pub 1/2012. PMID: 22261697. |
| 11. | Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Barton Grossman H, Gu J, Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Ryan Diver W, Gapstur SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Teresa Landi M, Fraumeni JF, Silverman DT, Chanock SJ, Wu X. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet 20(21):4282-9, 11/2011. e-Pub 8/2011. PMCID: PMC3188994. |
| 12. | Tan W, Hildebrandt MA, Pu X, Huang M, Lin J, Matin SF, Tamboli P, Wood CG, Wu X. Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes. J Urol 186(5):2071-7, 11/2011. e-Pub 9/2011. PMID: 21944129. |
| 13. | Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. Common Genetic Variants in Cell Cycle Pathway Are Associated with Survival in Stage III-IV Non-Small Cell Lung Cancer. Carcinogenesis. e-Pub 9/2011. PMID: 21965272. |
| 14. | Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis 32(7):1050-6, 7/2011. e-Pub 4/2011. PMCID: PMC3128559. |
| 15. | Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 103(10):817-25, 5/2011. e-Pub 4/2011. PMCID: PMC3096796. |
| 16. | Gu J, Chen M, Shete S, Amos CI, Kamat A, Ye Y,Lin J, Dinney CP, Wu X. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res (Phila) 4(4):514-21, 4/2011. e-Pub 4/2011. PMCID: PMC3076128. |
| 17. | Pu X, Hildebrandt MA, Lu C, Lin J, Stewart DJ, Ye Y, Gu J, Spitz MR, Wu X. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer 71(1):82-8, 1/2011. e-Pub 5/2010. PMCID: PMC2952281. |
| 18. | Yin J, Lu K, Lin J, Wu L, Hildebrandt MA, Chang DW, Meyer L, Wu X, Liang D. Genetic Variants in TGF-ß Pathway Are Associated with Ovarian Cancer Risk. PLoS One 6(9):e25559, 2011. e-Pub 9/2011. PMCID: PMC3184159. |
| 19. | Dai J, Gu J, Lu C, Lin J, Stewart D, Chang D, Roth JA, Wu X. Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer. PLoS One 6(6):e21120, 2011. e-Pub 6/2011. PMCID: PMC3117866. |
| 20. | Svatek RS, Shah JB, Xing J, Chang D, Lin J, McConkey DJ, Wu X, Dinney CP. A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer. Cancer 116(19):4513-9, 10/2010. PMID: 20572047. |
| 21. | Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 31(10):1805-12, 10/2010. e-Pub 8/2010. PMCID: PMC2981457. |
| 22. | Wang J, Lippman SM, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK, Wu X. Genetic Variations in Regulator of G-Protein Signaling Genes as Susceptibility Loci for Second Primary Tumor/Recurrence in Head and Neck Squamous Cell Carcinoma. Carcinogenesis 31(10):1755-61, 10/2010. e-Pub 7/2010. PMCID: PMC2950933. |
| 23. | Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, Chang J, Zhang X, Izzo J, Yang H, Lin J, Gu J, Chanock S, Kogevinas M, Rothman N, Silverman DT, Garcia-Closas M, Grossman HB, Dinney CP, Malats N, Wu X. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res (Phila) 3(10):1235-45, 10/2010. e-Pub 9/2010. PMCID: PMC2955764. |
| 24. | Lin J, Wang J, Greisinger AJ, Grossman HB, Forman MR, Dinney CP, Hawk ET, Wu X. Energy Balance, the PI3K-AKT-mTOR Pathway Genes and the Risk of Bladder Cancer. Cancer Prev Res (Phila) 3(4):505-17, 4/2010. e-Pub 3/2010. PMCID: PMC2867666. |
| 25. | Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, Pankratz VS, Su L, Li Y, Sun Z, Tang H, Vasmatzis G, Harris CC, Spitz MR, Jen J, Wang R, Zhang ZF, Christiani DC, Wu X, Yang P. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 11(4):321-30, 4/2010. e-Pub 3/2010. PMCID: PMC2945218. |
| 26. | Gu J, Ye Y, Spitz MR, Lin J, Kiemeney LA, Xing J, Hildebrandt MA, Ki Hong W, Amos CI, Wu X.. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. Hum Mol Genet, 2010. PMCID: PMC3024041. |
| 27. | Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K. Genetic Variants in MicroRNA Biosynthesis Pathways and Binding Sites Modify Ovarian Cancer Risk, Survival, and Treatment Response. Cancer Res 70:9765-76, 2010. PMID: 21118967. |
| 28. | Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X.. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29(42):5724-8, 2010. PMID: 20676129. |
| 29. | Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, Gu J, Wu X. Constitutive Short Telomere Length of Chromosome 17p and 12q but not 11q and 2p Is Associated with an Increased Risk for Esophageal Cancer. Cancer Prev Res (Phila Pa) 2(5):459-65, 2009. e-Pub 4/2009. PMCID: PMC2701666. |
| 30. | Lin J, Kamat A, Gu J, Chen M, Dinney CP, Forman MR, Wu X. Dietary Intake of Vegetables, Fruits and the Modification Effects of GSTM1, NAT2 Genotypes on Bladder Cancer Risk. Cancer Epidemiol Biomarkers Prev 18(7):2090-7, 2009. e-Pub 6/2009. PMID: 19549811. |
| 31. | Clague J, Lin J, Cassidy A, Matin S, Tannir NM, Tamboli P, Wood CG, Wu X. Family history and risk of Renal Cell Carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev 18(3):801-7, 2009. e-Pub 2/2009. PMCID: PMC2747496. |
| 32. | Pan J, Lin J, Izzo JG, Liu Y, Xing J, Huang M, Ajani JA, Wu X. Genetic Susceptibility to Esophageal Cancer: The Role of the Nucleotide Excision Repair Pathway. Carcinogenesis 30(5):785-792, 2009. e-Pub 3/2009. PMCID: PMC2675653. |
| 33. | Wu X, Ye Y, Kiemeney LA, et al.. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 41:991-5, 2009. PMID: 19648920. |
| 34. | Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, Hildebrandt MA, Lin J, Ye Y, Chamberlain RM, Dinney CP, Wu X. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis 30(12):2047-52, 2009. PMCID: PMC2792319. |
| 35. | Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, Lin J, Ajani JA, Wu X. Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway are Associated with Clinical Outcomes in Esophageal Cancer Patients Treated with Chemoradiotherapy. J Clin Oncol 27(6):857-71, 2009. e-Pub 1/2009. PMCID: PMC2738430. |
| 36. | Stern MC, Lin J, Figueroa JD, et al.. Polymorphisms in DNA Repair Genes, Smoking, and Bladder Cancer Risk: Findings from the International Consortium of Bladder Cancer. Cancer Res 69:6857-64, 2009. PMID: 19706757. |
| 37. | Cassidy A, Wang W, Wu X, Lin J. Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMI Cancer 15(9):443, 2009. PMID: 20146888. |
| 38. | Clague J, Shao L, Lin J, Chang S, Zhu Y, Wang W, Wood CG, Wu X. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis 30(4):706-10, 2009. e-Pub 2/2009. PMCID: PMC2722144. |
| 39. | Lin J, Pu X, Wang W, Matin S, Tannir NM, Wood CG, Wu X. Case-Control Analysis of Nucleotide Excision Repair Pathway and the Risk of Renal Cell Carcinoma. Carcinogenesis 29(11):2112-9, 2008. e-Pub 8/2008. PMCID: PMC2722861. |
| 40. | Margulis V, Lin J, Yang H, Wang W, Wood CG, Wu X. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway. Cancer Epidemiol Biomarkers Prev 17(9):2366-73, 2008. PMCID: PMC2581835. |
| 41. | Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X. Genetic Variations in MicroRNA-Related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk. Cancer Prev Res (Phila Pa) 1(6):460-469, 2008. PMCID: PMC2768267. |
| 42. | Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, Gu J, Hong WK, Stewart D, Spitz MR. Germline Genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics 18(11):955-65, 2008. PMCID: PMC2665725. |
| 43. | Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, Shields PG, Benowitz NL, Gu J, de Andrade M, Swan GE, Wu X. Mitochondrial DNA Content: Its Genetic Heritability and Association with Renal Cell Carcinoma. J Natl Cancer Inst 100(15):1113-1116, 2008. e-Pub 7/2008. PMCID: PMC2720693. |
| 44. | Zhu Y, Yang H, Chen Q, Lin J, Grossman HB, Dinney CP, Wu X, Gu J. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst) 7(2):141-8, 2008. e-Pub 10/2007. PMCID: PMC2254649. |
| 45. | Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, Wu X. Plasma Vitamins E and A and Risk of Bladder Cancer: a Case-Control Analysis. Cancer Causes Control 19(9):981-92, 2008. PMID: 18478342. |
| 46. | Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X. Single nucleotide polymorphisms of microRNA-machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14(23):7956-62, 2008. PMCID: PMC2650498. |
| 47. | Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 on chromosome 15q24025.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100(21):1552-1556, 2008. e-Pub 10/2008. PMCID: PMC2720751. |
| 48. | Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney CP, Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 120(10):2208-13, 2007. PMID: 17290402. |
| 49. | Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis 28(3):698-703, 2007. e-Pub 10/2006. PMID: 17052994. |
| 50. | Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev 16(1):84-91, 2007. PMID: 17220334. |
| 51. | Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer 120(12):2687-95, 2007. PMID: 17290394. |
| 52. | Kader AK, Liu J, Shao L, Dinney CP,Lin J, Wang Y, Gu J, Grossman HB, Wu X. Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. Clin Cancer Res 13(9):2614-20, 2007. PMID: 17473191. |
| 53. | Lin J, Swan GE, Shields PG, Benowitz NL, Gu J, Amos CI, de Andrade M, Spitz MR, Wu X. Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation. Cancer Epidemiol Biomarkers Prev 16(10):2065-71, 2007. PMID: 17932354. |
| 54. | Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 25(31):4974-81, 2007. PMID: 17971596. |
| 55. | Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X. Urinary Tract Diseases and Bladder Cancer Risk: a Case-Control Study. Cancer Causes Control 18(8):839-45, 2007. e-Pub 6/2007. PMID: 17593531. |
| 56. | Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer 107(4):705-11, 2006. PMID: 16845665. |
| 57. | Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM, Wu X. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27(10):2034-7, 2006. e-Pub 4/2006. PMID: 16638786. |
| 58. | Shao L, Hittelman WN, Lin J, Yang H, Ajani JA, Wu X. Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer. Mutat Res 602(1-2):143-50, 2006. e-Pub 10/2006. PMID: 17011594. |
| 59. | Lin J, Dinney CP, Grossman HB, Jhamb M, Zhu Y, Spitz MR, Wu X. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet 70:240-5, 2006. PMID: 16922727. |
| 60. | Wu X, Spitz MR, Amos CI, Lin J, Shao L, Gu J, de Andrade M, Benowitz NL, Shields PG, Swan GE. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res 15(12):5993-6, 2006. PMID: 16778168. |
| 61. | Lin J, Dinney CP, Grossman HB, Wu X. Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case-control study. Cancer Epidemiol Biomarkers Prev 15(9):1746-9, 2006. PMID: 16985040. |
| 62. | Lin J, Kadlubar FF, Spitz MR, Zhao H, Wu X. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev 14(7):1832-6, 2005. PMID: 16030125. |
| 63. | Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res 582(1-2):71-8, 2005. PMID: 15781212. |
| 64. | Shao L, Lin J, Huang M, Ajani JA, Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer 44(4):415-22, 2005. PMID: 16114035. |
| 65. | Gu J, Spitz MR, Zhao H, Lin J, Grossman HB, Dinney CP, Wu X. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis 26(10):1741-7, 2005. e-Pub 5/2005. PMID: 15905204. |
| 66. | Zhu Y, Spitz MR, Amos CI, Lin J, Schabath MB, Wu X. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res 64(6):2251-7, 2004. PMID: 15026370. |
| 67. | Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 25(9):1639-1647, 2004. e-Pub 4/2004. PMID: 15117811. |
